Related Experiment Video

Updated: Oct 3, 2026

Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats
11:13

Quantifying Glomerular Permeability of Fluorescent Macromolecules Using 2-Photon Microscopy in Munich Wistar Rats

Published on: April 17, 2013

Beta(2)-microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyzer membrane

Gerhard Lonnemann1, Karl M Koch

  • 1Department of Nephrology, Medizinische Hochschule Hannover, Hannover, Germany. GLonnemann@t-online.de

Journal of the American Society of Nephrology : JASN
|January 17, 2002
PubMed

Insights

Beta(2)-microglobulin amyloidosis (beta(2)mA) progresses through phases, starting with beta(2)m deposition in joints. Inflammation, driven by modified beta(2)m, causes tissue and bone destruction in advanced renal failure.

Area of Science:

  • Nephrology
  • Rheumatology
  • Pathophysiology

Background:

  • Beta(2)-microglobulin amyloidosis (beta(2)mA) is a progressive condition linked to end-stage renal failure.
  • Pathophysiology involves beta(2)m retention and deposition in joints.

Purpose of the Study:

  • To elucidate the phased pathophysiology of beta(2)mA.
  • To understand the role of beta(2)m modification and inflammation in disease progression.

Main Methods:

  • Review of available data on beta(2)mA pathophysiology.
  • Analysis of beta(2)m deposition, fibril formation, and inflammatory responses.

Main Results:

  • Beta(2)mA develops in distinct phases: beta(2)m retention and deposition, amyloid fibril formation, and inflammatory response.
  • Inflammation is triggered by advanced glycoxidation end product modification of beta(2)m, attracting macrophages and inducing cytokine release.
  • Unmodified beta(2)m also contributes to inflammation by upregulating COX-2 and MMP-1.
  • Inflammation severity correlates with tissue and bone destruction.

Conclusions:

  • Beta(2)mA progression is a multi-phase process involving beta(2)m deposition and subsequent inflammation.
  • Inflammatory mediators play a crucial role in the destructive nature of beta(2)mA.
  • Understanding these phases is key to managing beta(2)mA in patients with renal failure.

More Related Videos

Extraction and Purification of FAHD1 Protein from Swine Kidney and Mouse Liver12:07

Extraction and Purification of FAHD1 Protein from Swine Kidney and Mouse Liver

Published on: February 18, 2022

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

Related Concept Videos

Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...